12
Participants
Start Date
December 1, 2020
Primary Completion Date
June 30, 2022
Study Completion Date
May 23, 2023
Mixture 3,6% H2 in N2 (96.4%)
Route of administration: intra-nasal Debit 1L/min, 24h/24h (3 hours withdrawal tolerated) duration of treatment: 24 hours, 3 days and 6 days
CHU de Grenoble Alpes, Grenoble
University Hospital, Grenoble
OTHER